It is now recognized that intestinal mucosal uptake of small peptides, with cellular hydrolysis, occurs in many mammals including man, and is probably an important mode of protein absorption (Newey and Smyth, 1959; Craft et al., 1968; Adibi, 1971; Matthews, 1971a) . The nutritional importance of this mode of absorption in amino acid transport defects involving the small intestine was first suggested by investigations in a case of Hartnup disease Asatoor et al., 1970) . Tolerance tests showed that this patient absorbed L-histidine, L-tryptophan, and L-phenylalanine very poorly from the free amino acids, but comparatively well from dipeptides. It was suggested that retention of the ability to take up peptides, owing to the existence of an independent peptide transport system or systems, might explain the previously puzzling observation that there are no obvious symptoms of protein malabsorption in Hartnup disease, and no signs of malnutrition apart from a slight reduction in mean stature. Analogous findings were subsequently reported in cystinuria (Hellier, Perrett, and Holdsworth, 1970; Asatoor et al., 1971) . We report Received 28 February 1972. here a child with coeliac disease and a coexistent defect in intestinal and renal transport of neutral amino acids similar to, but not identical with, that present in classical Hartnup disease. Investigations of absorption of free amino acids and dipeptides by means of tolerance tests and transport studies in a jejunal biopsy have provided additional evidence for retention of the ability to take up dipeptides in the presence of an amino acid transport defect. Some of the results have already been briefly reported (Tarlow et al., 1970; Matthews, 1971b) .
Case Report The patient, a boy, is the first child ofPakistani parents who are first cousins. Pregnancy and delivery were normal, and he was well until the age of 8 months, when he became constipated, apathetic, and refused to feed. During the next few weeks he developed diarrhoea and lost weight. Symptoms were not influenced by the withdrawal of various sugars or of milk protein from the diet, and because of clinical deterioration he was treated with ACTH. Improvement was prompt with return of appetite and weight gain. At the age of 1 1 years he was referred to The Hospital for Sick Children, Great Ormond Street, for further investiga-798 tion. On admission his weight was 8 * 0 kg (below 3rd centile) and length 74 cm (between 10th and 25th centiles). There were no other abnormalities on physical examination and his developmental age corresponded with his chronological age. His appetite was good and he was eating a normal ward diet. ACTH was stopped as a prelude to investigation; clinical deterioration occurred within 2 weeks and he again became anorexic and lost weight.
Relevant investigations at this stage showed Hb 8-0 g/100 ml, serum cholesterol 96 mg/100 ml, serum folate 10-4 ng/ml, and serum iron 28 tLg/100 ml. Faecal fat was 4 * 0 g/day (mean of 3 days) on a total fat intake of 20 g/day. Barium meal showed widening of the small bowel lumen, with thickened mucosal folds. Peroral biopsy of the duodenal mucosa showed subtotal villous atrophy. Examination of the urine showed constant aminoaciduria (details given in a later section) but there was no proteinuria, glycosuria, or phosphaturia, and the urinary sediment was normal.
Renal acidification was also normal. There was no increase in plasma amino acids. A provisional diagnosis of coeliac disease was made and a gluten-free, disaccharide-free diet started. Shortly afterwards (1 week after starting the diet and 7 weeks after admission) there was further marked deterioration in his condition, with complete food refusal so that gavage feeding had to be instituted. A rash resembling that of pellagra developed; this consisted of a symmetrical erythematous eruption on the face, especially on the eyelids and around the mouth, and an erythematous hyperpigmented hyperkeratotic eruption particularly marked over the napkin area and thighs. An area of punctate perifollicular haemorrhages consistent with scurvy was present on the anterior abdominal wall. A vitamin C saturation test showed that only 14% of the dose was excreted in 3 hours (normal 50%). There was no suggestion of light sensitivity at this time, but the child had not in fact been outside a hospital ward, or exposed to bright sunlight, for several months. No evidence of cerebellar ataxia, or of any specific neurological deficit was detected at any time. Intravenous vitamins ('Parentrovite': B1 33 mg, nicotinamide 53 mg, riboflavine 1-3 mg, B6 16 5 mg, and ascorbic acid 100 mg daily) were given and both types of skin eruption cleared within 72 hours. The gluten-free diet was continued and he subsequently made satisfactory progress with return of normal appetite and bowel habit and gain in weight to 10 * 8 kg (25th centile). He was discharged home at the age of 1 * 4 years clinically well on a gluten-free and disaccharide-free diet with additional oral iron and vitamin supplements ('Ketovite' tablets 9 daily, and 'Ketovite' liquid 10 ml daily, which supplied 30 mg nicotanamide and 150 mg ascorbic acid).
After discharge he remained symptom free, but his growth progress was not entirely satisfactory, and it became clear that a strictly gluten-free diet was not being maintained. He was therefore readmitted for reassessment at the age of 2 4 years when his weight was 13-4 kg (on the 50th centile) and height 85 cm (on the 10th centile). There was no neurological or intellectual deficit, and no rash. Peroral intestinal biopsy from the region of the ligament of Treitz again showed subtotal villous atrophy with considerable epithelial dysplasia. The aminoaciduria was still present (see later section). Disaccharides were introduced into his diet without any clinical reaction or the appearance of sugar in stools or urine; a strict glutenfree diet was re-established and he was discharged on this regimen together with additional vitamins as previously, and a further 50 mg nicotinamide daily. Subsequent clinical progress was improved and by the age of 3 4 years his weight (16-5 kg) was on the 75th centile and height (98 cm) on the 50th centile.
Special Studies of Amino Acids and of Peptide Absorption 1st admission. Two-dimensional paper chromatography showed that the plasma amino acid pattern was normal, but revealed a constant heavy aminoaciduria, with large amounts of asparagine, glutamine, serine, threonine, alanine, phenylalanine, tyrosine, and histidine; proline was absent. No glycosuria was detected.
During this admission, but at a time when he was clinically well (i.e. after clinical response to the glutenfree diet had been established), oral loads of L-phenylalanine, L-valine, and L-histidine (100 mg/kg body weight), and L-tyrosine (300 mg/kg) were given with a marker (Seakins and Ersser, 1967) . Faecal amino acids were estimated after all four loads and serial plasma values were measured after phenylalanine and valine. No excess amino acid was found in the marked stools passed after the loads of phenylalanine, valine, and histidine, but approximately half the tyrosine given was recovered in the corresponding stool (normal values less than 10% of dose). The plasma curves for phenylalanine and valine were within the normal ranges obtained in the laboratory. 2nd admission. At this time when he was clinically well, but still had subtotal villous atrophy, urinary amino acid chromatography showed gross aminoaciduria as previously. The following loads were given on alternate days: L-tyrosine (100 mg/kg), Lhistidine (100 mg/kg), and equivalent molar quantities of glycyl-L-tyrosine and glycyl-L-histidine. Plasma samples were obtained at 30-minute intervals for 3 hours and the results are shown in Fig. 1 and 2 . Urine was collected for 6 hours after each load. Urine and plasma amino acid concentrations were assayed by ion-exchange chromatography (Thomas, 1970) . The system used was designed for protein hydrolysates, and it was not possible to quantitate asparagine, glutamine, serine, and threonine because of overlapping.
The collection of timed urine and plasma samples during these loads enabled several estimations of renal clearance rates for 13 amino acids over the 6-hour period of the test to be made. In Table II .
Discussion
The diagnosis of coeliac disease in our patient rests on the typical appearance of the small intestinal mucosa and the response to a gluten-free diet. The persistent abnormality in the intestinal mucosa at the time of the second admission is explained by the failure to adhere to a strictly gluten-free diet, and though dietary control was improved thereafter with subsequent acceleration in both height and weight gain, the religious beliefs and language problems of the family make it unlikely that a completely gluten-free diet will ever be achieved at home.
The diagnosis of Hartnup disease was suggested by the finding of a constant neutral aminoaciduria and the development of a pellagrous rash which rapidly cleared on the administration of an intravenous multivitamin preparation containing nicotinamide. There is no suggestion in the literature of any connexion between coeliac disease and Hartnup disease, and the persistence of the aminoaciduria in our patient after the initial malnutrition had been corrected virtually eliminates the possibility that the aminoaciduria was secondary to the coeliac disease. It may be, though, that the added malnutrition of coeliac disease provoked clinical manifestations of Hartnup disease in a patient who would otherwise have been asymptomatic. It has been pointed out by other workers that clinical symptoms of Hartnup disease are often preceded by a period of undernutrition (Jepson, 1966; Navab and Asatoor, 1970) .
More detailed studies of the amino acid transport defect in our patient showed that it differed in certain respects from that found in classical Hartnup disease. The renal clearance of the branched chain amino acids was only slightly raised above normal. The absorption of histidine and tyrosine, two amino acids which had the highest renal clearance, was poor as judged by the plasma response after oral loads, and in the case of tyrosine by the appearance of an excess of this amino acid in the faeces. In contrast, oral loading tests failed to show impaired absorption of valine and phenylalanine, two amino acids with only slightly raised renal clearances. It is concluded therefore that our patient exhibits a variant of Hartnup disease, and if this interpretation of the experimental data is correct, the absorption of the branched chain amino acids may differ in some respects from that of the other neutral amino acids.
A reduced ability of intestinal biopsy specimens to concentrate dibasic amino acids and cystine has been shown in cystinuria (Thier et al., 1965; McCarthy et al., 1964) ; more recently, a reduction in biopsy uptake of tryptophan and methionine has been shown in Hartnup disease (Shih et al., 1971) .
Our studies extend these observations and provide the first evidence that an amino acid (histidine) for which there is an intestinal transport defect is taken up by intestinal mucosa in vitro to a much greater extent when presented in the form of a dipeptide. The biopsy from our 'Hartnup' patient took up histidine very poorly from the free amino acid and failed to concentrate it under conditions in which a control biopsy (also affected by coeliac disease) took up 6 times as much histidine and concentrated it against a gradient. When incubated in glycylhistidine, however, the 'Hartnup' biopsy took up more than 3 times as much histidine as from the free amino acid. Histidine uptake from this peptide was nearly as great as that of glycine (an amino acid which is unaffected or only minimally affected by the transport defect of Hartnup disease). The possibility that the threefold difference in uptake of histidine from free amino acid and dipeptide was the result of chance variation between two halves of the same biopsy specimen is remote. Steiner et al. (1969) reported that estimates of amino acid uptake by duplicate biopsy specimens agreed within ±10%. An interesting feature of this case is that though the biopsy showed evidence of ability to take up histidine from glycylhistidine, the tolerance curves did not suggest that histidine absorption from this peptide was any better than from the free amino acid. Shih et al. (1971) , using methionine, also found a discrepancy between the results of biopsy uptake and those of a tolerance test. The reasons for such discrepancies are unknown. It may be that the tehaviour of a biopsy from one site does not reflect the behaviour of the relatively large area of intestine involved in transport when a substance is given orally. In contrast to the glycylhistidine tolerance test, the glycyltyrosine tolerance test clearly showed superior absorption of the 'affected' amino acid when presented in peptide form.
The possibilities that the abnormalities of amino acid absorption were due to coeliac disease rather that Hartnup disease has to be considered. The fact that the tolerance curve for free tyrosine was flat whereas that following glycyltyrosine showed a great increase in this amino acid shows tl at nonspecific mucosal damage cannot be the explanation. This conclusion is supported by the ability of a jejunal biopsy from another patient with coeliac disease to concentrate free histidine. The results of loth in vivo and in vitro investigations support the hypothesis that intestinal transport of certain neutral amino acids is defective in Hartnup disease, but that the ability of the intestinal mucosa to take up dipeptides containing these amino acids is retained. They confirm that intestinal uptake of peptides plays a part in protein absorption in man, and that this mode of absorption is likely to be of particular nutritional importance in Hartnup disease.
